Symposium 5











Attenzione: apre in una nuova finestra.

5 Monday, September 3, 7:45 - 10:00 am
Pediatrics

Chairs:
S.R. Jadcherla (Columbus) – S. Nurko (Boston)
Discussant: M. Chehade (New York)

  • What is the definition of GERD in infants and children? S. Nurko (Boston)
  • What is the natural history of GER and GERD that starts in infants and children? M. Thomson (Sheffield)
  • What are the underlying mechanisms that generate symptoms in GERD in children? N. Tipnis (San Diego)
  • What are the upstream and downstream reflexes that protect against esophageal provocation in infants and children? S.R. Jadcherla (Columbus)
  • How do you evaluate GERD? R. Rosen (Boston)
  • What is the best way to determine symptom association with GER events in infants and children? R. Rosen (Boston)
  • Potential biomarkers for GERD R. Rosen (Boston)
  • What are the non-pharmacological approaches of managing GER and GERD in infants and children? S.R. Jadcherla (Columbus)
  • Benefits and risks of pharmacological approaches in managing GER and GERD in infants and children? M. Thomson (Sheffield)
  • Are the new pediatric GERD guidelines applicable to clinical practice? S. Nurko (Boston)